Gridai Technologies Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.98

+0.52 (+11.66%)

As of Jun 30, 4:40 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +767.5% upside

Low Target $28.55

Average Target $43.20

High Target $44.32

Current Price $4.98

Current
$4.98

Target
$43.20

$28.55 $43.20 avg $44.32

Scenario Analysis

Bear Case

$28.55

473.3%

Low target

Base Case

$43.20

+767.5%

Avg target

Bull Case

$44.32

+790.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$6.93

-28.1% from high

52-Week Low

$1.08

+361.1% from low

Target vs 52W High

$43.20

+523.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%